Published in Health Business Week, January 7th, 2005
Under the terms of the agreements, each of the distributors has agreed to purchase a minimum number of doses of Fluviral vaccine from ID Biomedical beginning upon U.S. Food and Drug Administration (FDA) clearance. The purchases could begin as early as next year, and will end after the 2014/2015 flu season.
It is the expectation of the parties that ID Biomedical's Fluviral will be licensed in the U.S. by at least the 2007/08 influenza season,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week